{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:14:28Z","timestamp":1775481268985,"version":"3.50.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/aco.0b013e3283532007","type":"journal-article","created":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T14:15:40Z","timestamp":1333462540000},"page":"309-314","source":"Crossref","is-referenced-by-count":27,"title":["The role of recombinant activated factor VII in obstetric hemorrhage"],"prefix":"10.1097","volume":"25","author":[{"given":"Jouni","family":"Ahonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210129","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1055\/s-0038-1665434","article-title":"The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.","volume":"78","author":"Hay","year":"1997","journal-title":"Thromb Haemost"},{"key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1172\/JCI116691","article-title":"The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor.","volume":"92","author":"ten Cate","year":"1993","journal-title":"J Clin Invest"},{"key":"R3-7-20210129","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0268-960X(03)90000-2","article-title":"A cell-based model of coagulation and the role of factor VIIa.","volume":"17","author":"Hoffman","year":"2003","journal-title":"Blood Rev"},{"key":"R4-7-20210129","first-page":"S61","article-title":"Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.","volume":"9","author":"Hoffman","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-939557","article-title":"Mechanism of action of factor VIIa in the treatment of coagulopathies.","volume":"32","author":"Hedner","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R6-7-20210129","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1399-6576.2010.02309.x","article-title":"Management of postpartum haemorrhage.","volume":"54","author":"Ahonen","year":"2010","journal-title":"Acta Anaesthesiol Scand"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2141.2001.02878.x","article-title":"Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII.","volume":"113","author":"Moscardo","year":"2001","journal-title":"Br J Haematol"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/bja\/aei094","article-title":"Recombinant factor VIIa for life-threatening postpartum haemorrhage.","volume":"94","author":"Ahonen","year":"2005","journal-title":"Br J Anaesth"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1080\/00016340701619324","article-title":"Use of recombinant activated factor VII for massive postpartum hemorrhage.","volume":"86","author":"Hossain","year":"2007","journal-title":"Acta Obstet Gynecol"},{"key":"R11-7-20210129","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/01.AOG.0000288515.48066.99","article-title":"Use of recombinant activated factor VII in primary postpartum hemorrhage.","volume":"110","author":"Alfirevic","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R12-7-20210129","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1399-6576.2007.01323.x","article-title":"An open nonrandomized study of recombinant activated factor VII in major postpartum haemorrhage.","volume":"51","author":"Ahonen","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejogrb.2007.06.022","article-title":"Use of recombinant activated factor VII in massive postpartum haemorrhage.","volume":"137","author":"Bouma","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.thromres.2009.08.018","article-title":"Use of recombinant activated factor VII in massive postpartum haemorrhage: data from the Italian registry. A multicentric observational study.","volume":"124","author":"Barillari","year":"2009","journal-title":"Thromb Res"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1213\/ANE.0b013e3181c039e6","article-title":"Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand haemostasis registry.","volume":"109","author":"Phillips","year":"2009","journal-title":"Anesth Analg"},{"key":"R17-7-20210129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2008-1066022","article-title":"A critical review of the use of recombinant factor VIIa in life-threatening obstetric postpartum haemorrhage.","volume":"34","author":"Franchini","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/GRF.0b013e3181cc4378","article-title":"The use of recombinant activated FVII in postpartum hemorrhage.","volume":"53","author":"Franchini","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1521-6934(03)00019-1","article-title":"Haemostasis in normal and abnormal pregnancy.","volume":"17","author":"ORiordan","year":"2003","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9378(98)70389-8","article-title":"Hemostasis in the uteroplacental and peripheral circulations in normotensive and preeclamptic pregnancies.","volume":"179","author":"Higgins","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1538-7836.2004.01108.x","article-title":"D-dimer levels during delivery and the postpartum.","volume":"3","author":"Epiney","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R22-7-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.aia.0000182640.39691.dd","article-title":"Coagulopathy in massive transfusion.","volume":"43","author":"Wojciechowski","year":"2005","journal-title":"Int Anesthesiol Clin"},{"key":"R23-7-20210129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0301-2115(03)00287-2","article-title":"Clinical observation of blood loss reduced by tranexamic acid during and after caesarean section: a multicenter, randomized trial.","volume":"112","author":"Gai","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R24-7-20210129","first-page":"227","article-title":"Efficacy of tranexamic acid in decreasing blood loss during and after cesarean section: a randomized case controlled prospective study.","volume":"57","author":"Mayur","year":"2007","journal-title":"J Obstet Gynecol India"},{"key":"R25-7-20210129","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc10143","article-title":"High-dose tranexamic acid reduces blood loss in postpartum haemorrhage.","volume":"15","author":"Ducloy-Bouthors","year":"2011","journal-title":"Crit Care"},{"key":"R26-7-20210129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2393-9-29","article-title":"Antifibrinolytic agents in postpartum haemorrhage: a systematic review.","volume":"9","author":"Ferrer","year":"2009","journal-title":"BMC Pregnancy and Childbirth"},{"key":"R27-7-20210129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/ACO.0b013e32832678d9","article-title":"Time for changing coagulation management in trauma-related massive bleeding.","volume":"22","author":"Fries","year":"2009","journal-title":"Curr Opin Anaesthesiol"},{"key":"R28-7-20210129","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00000542-200509000-00031","article-title":"Effects of hydroxyethyl starch solutions on hemostasis.","volume":"103","author":"Kozek-Langenecker","year":"2005","journal-title":"Anesthesiology"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/ALN.0b013e3181a7ec82","article-title":"Hydroxyethyl starches.","volume":"111","author":"Westphal","year":"2009","journal-title":"Anesthesiology"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1213\/01.ane.0000280481.18570.27","article-title":"Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration.","volume":"105","author":"Mittermayr","year":"2007","journal-title":"Anesth Analg"},{"key":"R31-7-20210129","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bja\/aem363","article-title":"Effect of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo.","volume":"100","author":"Mittermayr","year":"2008","journal-title":"Br J Anaesth"},{"key":"R32-7-20210129","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1160\/TH05-06-0424","article-title":"The influence of the haematocrit on primary haemostasis in vitro.","volume":"94","author":"Eugster","year":"2005","journal-title":"Thromb Haemost"},{"key":"R33-7-20210129","doi-asserted-by":"crossref","first-page":"24259","DOI":"10.1016\/S0021-9258(18)35759-4","article-title":"The effect of fibrin structure on fibrinolysis.","volume":"267","author":"Gabriel","year":"1992","journal-title":"J Biol Chem"},{"key":"R34-7-20210129","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0049-3848(94)90227-5","article-title":"Fibrin in the human plasma: gel architectures governed by rate and nature of fibrinogen activation.","volume":"75","author":"Blomback","year":"1994","journal-title":"Thromb Res"},{"key":"R35-7-20210129","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/s-0037-1613258","article-title":"The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding.","volume":"88","author":"Al Dieri","year":"2002","journal-title":"Thromb Haemost"},{"key":"R36-7-20210129","first-page":"41","article-title":"What does it take to make the perfect clot Arterioscler Thromb Vasc B","volume":"26","author":"Monroe","year":"2006","journal-title":"iol"},{"key":"R37-7-20210129","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1538-7933.2003.00617.x","article-title":"Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system.","volume":"2","author":"Allen","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R38-7-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1399-6576.2005.00602.x","article-title":"Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.","volume":"49","author":"Nielsen","year":"2005","journal-title":"Acta Anaesthesiol Scand"},{"key":"R39-7-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.curobgyn.2003.12.004","article-title":"Massive postpartum haemorrhage and management of disseminated intravascular coagulation.","volume":"14","author":"Macphail","year":"2004","journal-title":"Curr Obstet Gynaecol"},{"key":"R40-7-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.blre.2009.04.002","article-title":"Disseminated intravascular coagulation in obstetric disorders and its acute haematological management.","volume":"23","author":"Thachil","year":"2009","journal-title":"Blood Rev"},{"key":"R41-7-20210129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage.","volume":"5","author":"Charbit","year":"2007","journal-title":"J Thrombost Haemost"},{"key":"R42-7-20210129","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/TA.0b013e3181271ba3","article-title":"The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital.","volume":"63","author":"Borgman","year":"2007","journal-title":"J Trauma"},{"key":"R43-7-20210129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1479-828X.2007.00823.x","article-title":"Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.","volume":"48","author":"Welsh","year":"2008","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R44-7-20210129","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijoa.2006.07.005","article-title":"Use of recombinant activated factor VII in massive obstetric haemorrhage.","volume":"16","author":"Haynes","year":"2007","journal-title":"Int J Obstet Anesth"},{"key":"R45-7-20210129","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1537-2995.2008.02029.x","article-title":"Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage.","volume":"49","author":"Lewis","year":"2009","journal-title":"Transfusion"},{"key":"R46-7-20210129","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1538-7836.2008.02961.x","article-title":"Ante- and postnatal risk factors for venous thrombosis: a hospital-based case-control study.","volume":"6","author":"Jacobsen","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R47-7-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9490","article-title":"Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic review of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprohylaxis.","volume":"9","author":"Roderick","year":"2005","journal-title":"Health Technol Assess"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0b013e3283532007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:54:10Z","timestamp":1620942850000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001503-201206000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0b013e3283532007","relation":{},"ISSN":["0952-7907"],"issn-type":[{"value":"0952-7907","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}